'Focus on oncology: Cancer drugs - the economic challenge'

Karol Sikora assesses to what extent health technology assessments, the ageing population
and societal changes will influence the future of cancer care

Cancer care costs are spiralling out of control in every healthcare environment. Ageing populations are ‘consuming’ healthcare in vastly increasing quantities. And new technology – drugs, devices and procedures – is increasing the cost of care. At the same time, top-up payments are increasingly used to break treatment-access barriers. In such an environment, cancer patients are beginning to become very sophisticated consumers of clinical services. How much we are willing to pay for an extra year of good quality life is a key consideration for cancer patients of the baby boomer generation. For healthcare providers, the question is "how should people be asked to contribute to their care in an equitable way?"

view pdf

Cutting-edge cancer services launched under new partnership between CancerPartners UK and Spire Healthcare

CancerPartners UK and leading private hospital provider Spire Healthcare this week announced a partnership that will see the organisation provide cutting edge cancer treatments on three Spire hospital sites - the first private radiotherapy services outside London.


Main release   Trade release